• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.26% Nasdaq Down0.34%

    Akorn, Inc. (AKRX)

    -NasdaqGS
    43.46 Up 0.09(0.21%) 4:00PM EDT
    |After Hours : 43.46 0.00 (0.00%) 4:42PM EDT
    Add to Portfolio
    ProfileGet Profile for:
    Akorn, Inc.
    1925 West Field Court
    Suite 300
    Lake Forest, IL 60045
    United States - Map
    Phone: 847-279-6100
    Website: http://www.akorn.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Drugs - Generic
    Full Time Employees:1,644

    Business Summary 

    Akorn, Inc. develops, manufactures, and markets generic and branded prescription pharmaceuticals, as well as animal and over-the-counter (OTC) consumer health products in the United States and internationally. It operates through two segments, Prescription Pharmaceuticals and Consumer Health. The Prescription Pharmaceuticals segment markets generic and branded ophthalmics, injectables, oral liquids, otics, topical, inhalants, and nasal sprays. This segment’s generic products include Clobetasol Propionate, a corticosteroid, which is used to treat various skin conditions; Fluticasone Propionate, a corticosteroid used for nasal symptoms of allergic and non-allergic rhinitis conditions; Lidocaine/Prilocaine, a topical anesthetic; Progesterone, which is used to prevent endometrial hyperplasia; Vancomycin, an antibiotic used to treat bacterial infections; and other products. The Consumer Health segment markets branded and private label animal health products, as well as OTC products for the treatment of dry eye under the TheraTears brand name. This segment’s branded products comprise Akten, a topical ocular anesthetic gel; AzaSite, an antibiotic used to treat bacterial conjunctivitis; Cosopt, Cosopt PF, Betimol, and Zioptan, which are used in the treatment of glaucoma; Nembutal, a sedative; and Xopenex inhalation solution for the treatment or prevention of bronchospasm. It also markets other OTC consumer health products, including Mag-Ox, a diabetes magnesium supplement, and the Zostrix brand of capsaicin products for pain management; and animal health branded and generic products comprising Anased, Tolazine, Yobine, Butorphic, and VetaKet. Akorn, Inc. was founded in 1971 and is headquartered in Lake Forest, Illinois.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Akorn, Inc.

    Corporate Governance 
    Akorn, Inc.’s ISS Governance QuickScore as of Jun 1, 2015 is 10. The pillar scores are Audit: 10; Board: 9; Shareholder Rights: 4; Compensation: 7.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
     PayExercised
    Mr. Rajat Rai , 48
    Chief Exec. Officer
    2.25M73.51M
    Mr. Timothy A. Dick , 45
    Chief Financial Officer and Principal Accounting Officer
    392.00K19.59M
    Dr. Bruce Kutinsky Pharm.D., 49
    Chief Operating Officer
    683.00K0.00
    Mr. Joseph Bonaccorsi , 50
    Sr. VP, Gen. Counsel and Sec.
    527.00K9.27M
    Mr. John R. Sabat , 65
    Sr. VP of National Accounts and Trade Relations
    474.00K1.67M
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders